Muromonab cd3

Author:Prof. Dr. med. Peter Altmeyer

Last updated on: 29.10.2020

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).

Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Immunosuppressant.

Pharmacodynamics (Effect)This section has been translated automatically.

Monoclonal antibody against the T3 antigen of human T cells.

IndicationThis section has been translated automatically.

Prophylaxis of rejection reactions after heart, liver or kidney transplantation; for the treatment of autoimmune diseases currently in clinical trials.

Dosage and method of useThis section has been translated automatically.

5 mg/day i.v., 1-4 hours before first administration 8 mg/kg bw methylprednisolone i.v. (to avoid allergic reactions).

Undesirable effectsThis section has been translated automatically.

See Table 1.

InteractionsThis section has been translated automatically.

See Table 2.

ContraindicationThis section has been translated automatically.

Pregnancy, lactation, hypersensitivity to mouse products (anti-mouse antibodies > 1:1000), water retention, heart failure, seizures in the medical history.

PreparationsThis section has been translated automatically.

Orthoclone OKT 3

TablesThis section has been translated automatically.

Major side effects of Muromonab CD3

Airways	Dyspnoea, bronchospasm, flu-like symptoms Respiratory arrest Hyperventilation Pulmonary oedema, pneumonia, pneumonitis
Blood, lymph	aplastic anemia Blood coagulation disorders Eosinophilia leukocytosis, leukopenia, pancytopenia Splenomegaly, lymphadenopathy, lymphomas
GIT	Abdominal pain, gastrointestinal disturbances Transaminase increase hepatitis, hepatomegaly
Urinary tract	Anuria, Oliguria Glomerulonephritis Urea and creatinine increase
Skin	herpes simplex Pruritus, erythema, exanthema, urticaria, Quincke's edema, anaphylactic reactions spinocellular carcinomas
Cardiovascular	Hypertension, tachycardia Angina pectoris, cardiac arrhythmia, myocardial infarction temporal arteritis Thrombosis Subarachnoid hemorrhage
Nervous System	Headaches Rigor, Tremor loss of consciousness, delirium, hallucinations encephalopathy, brain edema Seizures aseptic meningitis Tetraplegia
Sensory Organs	double images, blurred vision, reduced vision to blindness conjunctivitis, photophobia Rotational vertigo hearing loss, tinnitus, otitis media
Support apparatus	Arthralgia, Myalgia Muscle twitching
System reactions	30-60 min. after administration: fever, chills

Significant interactions of Muromonab CD3

Azathioprine	Encephalopathy, infections, carcinogenicity ↑
Ciclosporin A	Encephalopathy, infections, carcinogenicity ↑
Glucocorticoids	Encephalopathy, infections, carcinogenicity ↑
Indomethacin	Encephalopathy

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer